Home | Find A Doctor | Contact Us

 

Accelerated Radiation Therapy in Early Stage Breast Cancer with an Infield Concomitant Boost using Intensity Modulated Radiation Therapy Techniques.

Principal Investigator:  
Time frame of study: Ongoing
Location of Study:

Mount Sinai Beth Israel
St.Luke's-Mount Sinai Roosevelt

Contact:

Continuum Cancer Research Program
(212) 844-6286

Summary:
In the traditional management of early stage breast cancer, breast conserving surgery (lumpectomy) is followed by a 6-7 week course of radiation therapy to the breast in order to minimize tumor recurrence. Recent clinical data from European and Canadian studies suggest that a shorter course of treatment is just as safe and effective. Currently, we have a breast cancer trial that aims to complete the entire radiation treatment course in 3 weeks instead of 6-7 weeks.

Eligibility:
Patients with early stage lymph node negative breast cancer who have received a lumpectomy as part of their treatment regimen. Patients receiving Tamoxifen/Arimidex can participate; however, currently we are not including patients that are receiving adjuvant chemotherapy. Please call for more information.

Benefits:
There is no monetary compensation for this study.

 

Privacy Policy | Site Map
Copyright ©  Icahn School of Medicine at Mount Sinai | Mount Sinai Health System